Akums Drugs & Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Akums Drugs & Pharma	Procter&Gamble Healt	Sanofi India
Operational Metrics
Pharmaceuticals
DMF Filingsby API	20.0 .	n/a	n/a
R&D as a % of Total Sales	0.7 %	n/a	0.0
Financials
5 yr Average ROE	7.64 %	36.03 %	50.34 %
5yr average Equity Multiplier	3.58	1.79	5.32
5yr Average Asset Turnover Ratio	1.18	0.77	0.42
5yr Avg Net Profit Margin	1.67 %	19.19 %	22.84 %
Price to Book	2.46	14.16	9.9
P/E	31.91	29.9	23.95
5yr Avg Cash Conversion Cycle	41.09 Days	-155.74 Days	-15.2 Days
Inventory Days	60.56 Days	36.01 Days	67.68 Days
Days Receivable	71.09 Days	40.92 Days	35.69 Days
Days Payable	82.93 Days	215.28 Days	75.12 Days
5yr Average Interest Coverage Ratio	6.26	500.05	777.41
5yr Avg ROCE	6.7 %	30.21 %	23.73 %
5yr Avg Operating Profit Margin	6.07 %	27.53 %	25.16 %
5 yr average Debt to Equity	0.43	0.0	0.0
5yr CAGR Net Profit	22.48 %	4.02 %	25.59 %
5yr Average Return on Assets	1.78 %	15.5 %	9.68 %
Shareholdings
Promoter Holding	75.26 %	51.82 %	60.4 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	5.77 %	2.86 %	-0.27 %

	Akums Drugs & Pharma	Procter&Gamble Healt	Sanofi India
Product Wise Break-Up	Product Wise Break-Up CDMO 78.18 Branded and generic formulations 16.74 API 5.09 Pharmaceuticals 0	-	Product Wise Break-Up API 0 CDMO 0 Branded and generic formulations 0 Pharmaceutical 100.0
Location Wise Break-Up	Location Wise Break-Up India 93.55 Outside India 6.45 International 0 Domestic 0 Singapore 0	Location Wise Break-Up International 6.81 Outside India 0 Domestic 93.19 India 0 Singapore 0	Location Wise Break-Up International 0 Outside India 0 Domestic 0 India 79.71 Singapore 20.29
Operating Profit Break-Up	Operating Profit Break-Up CDMO 88.08 Branded and generic formulations 11.92 API`s 0	-	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise CDMO 76.41 API`s 14.71 Branded and generic formulations 8.88	-	-